1. Home
  2. LGO vs MGNX Comparison

LGO vs MGNX Comparison

Compare LGO & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGO
  • MGNX
  • Stock Information
  • Founded
  • LGO 1988
  • MGNX 2000
  • Country
  • LGO Canada
  • MGNX United States
  • Employees
  • LGO N/A
  • MGNX N/A
  • Industry
  • LGO
  • MGNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGO
  • MGNX Health Care
  • Exchange
  • LGO Nasdaq
  • MGNX Nasdaq
  • Market Cap
  • LGO 100.0M
  • MGNX 99.7M
  • IPO Year
  • LGO 2007
  • MGNX 2013
  • Fundamental
  • Price
  • LGO $1.50
  • MGNX $1.73
  • Analyst Decision
  • LGO Strong Buy
  • MGNX Hold
  • Analyst Count
  • LGO 1
  • MGNX 5
  • Target Price
  • LGO $3.70
  • MGNX $3.25
  • AVG Volume (30 Days)
  • LGO 132.7K
  • MGNX 922.3K
  • Earning Date
  • LGO 08-12-2025
  • MGNX 11-04-2025
  • Dividend Yield
  • LGO N/A
  • MGNX N/A
  • EPS Growth
  • LGO N/A
  • MGNX N/A
  • EPS
  • LGO N/A
  • MGNX N/A
  • Revenue
  • LGO $108,526,000.00
  • MGNX $165,495,000.00
  • Revenue This Year
  • LGO N/A
  • MGNX N/A
  • Revenue Next Year
  • LGO $54.96
  • MGNX N/A
  • P/E Ratio
  • LGO N/A
  • MGNX N/A
  • Revenue Growth
  • LGO N/A
  • MGNX 303.47
  • 52 Week Low
  • LGO $1.12
  • MGNX $0.99
  • 52 Week High
  • LGO $2.84
  • MGNX $5.10
  • Technical
  • Relative Strength Index (RSI)
  • LGO 55.80
  • MGNX 51.74
  • Support Level
  • LGO $1.32
  • MGNX $1.69
  • Resistance Level
  • LGO $1.56
  • MGNX $2.22
  • Average True Range (ATR)
  • LGO 0.08
  • MGNX 0.16
  • MACD
  • LGO 0.00
  • MGNX 0.01
  • Stochastic Oscillator
  • LGO 75.00
  • MGNX 37.18

About LGO Largo Inc.

Largo Inc is committed to the production and supply of high-quality vanadium products. The company is also focused on the advancement of renewable energy storage solutions through Largo Clean Energy and its vanadium redox flow battery technology. The Company is engaged in the mining, exploration, and development of mineral properties, predominantly in Brazil, through which it produces and supplies vanadium products VPURE Flake, VPURE+ Flake, and VPURE+ Powder. The company has operating segments: sales & trading, mine properties, which generates key revenue, corporate, exploration and evaluation properties, Clean Energy, and Largo Physical Vanadium.

About MGNX MacroGenics Inc.

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. The company has three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload.

Share on Social Networks: